Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 2Phase NA 1

Status

Recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Genitourinary 1

Conditions

Rectal Neoplasms 1Pancreatic Neoplasms 1PDAC - Pancreatic Ductal Adenocarcinoma 1Colorectal Neoplasms 1Anastomotic Leak 1

Interventions

Oxaliplatin 780Fluorouracil 638Capecitabine 575Gemcitabine 478Leucovorin 459Bevacizumab 445Irinotecan 444Cisplatin 338Radiotherapy 283Cetuximab 252Paclitaxel 180S 1 (combination) 176pembrolizumab 173Docetaxel 156Drug Therapy 147Nivolumab 146sintilimab 143tislelizumab 131apatinib 131130-nm albumin-bound paclitaxel 128Folfox protocol 121durvalumab 119Albumin-Bound Paclitaxel 117camrelizumab 107lenvatinib 106Panitumumab 106regorafenib 102Surgical Procedures, Operative 102Sorafenib 99Radiation 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Ciprofloxacin × Gastrointestinal × Clear all
NCT06728072 2026-05-06

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Virginia Commonwealth University

Phase 2 Recruiting
97 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07028424 2025-07-01

PANORAMIX

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Not yet recruiting
206 enrolled
Gastrointestinal

PDAC - Pancreatic Ductal Adenocarcinoma

NCT05462496 2024-10-15

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

Icahn School of Medicine at Mount Sinai

Phase 2 Recruiting
25 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02682485 2023-04-26

SES-DTA

University of Chicago

Phase 2 Withdrawn
Gastrointestinal

Rectal Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon âš¡